These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34455948)

  • 1. A Systematic Review and Meta-Analysis of the Safety of Hydroxychloroquine in a Randomized Controlled Trial and Observational Studies.
    Konwar M; Maurya M; Thatte UM; Gogtay NJ; Bose D
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):216-235. PubMed ID: 34455948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
    Eljaaly K; Alireza KH; Alshehri S; Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 36():101812. PubMed ID: 32645478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
    Chen C; Pan K; Wu B; Li X; Chen Z; Xu Q; Li X; Lv Q
    Eur J Clin Pharmacol; 2021 Jan; 77(1):13-24. PubMed ID: 32780229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Kashour Z; Kashour T; Gerberi D; Tleyjeh IM
    Clin Transl Sci; 2021 May; 14(3):1101-1112. PubMed ID: 33606894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
    Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
    J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    Front Pharmacol; 2020; 11():562777. PubMed ID: 33154723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of hydroxychloroquine in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.
    Singh A; Kotlo A; Wang Z; Dissanayaka T; Das S; Antony B
    Korean J Intern Med; 2022 Jan; 37(1):210-221. PubMed ID: 33882635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    medRxiv; 2020 May; ():. PubMed ID: 32511539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.
    Di Castelnuovo A; Costanzo S; Cassone A; Cauda R; De Gaetano G; Iacoviello L
    Pathog Glob Health; 2021; 115(7-8):456-466. PubMed ID: 34128772
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials.
    Hong H; Friedland A; Hu M; Anstrom KJ; Halabi S; McKinnon JE; Amaravadi R; Rojas-Serrano J; Abella BS; Portillo-Vázquez AM; Woods CW; Hernandez AF; Boulware DR; Naggie S; Rajasingham R
    BMJ Open; 2023 Jun; 13(6):e065305. PubMed ID: 37328184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
    Choudhuri AH; Duggal S; Ahuja B; Biswas PS
    Indian J Med Microbiol; 2021 Apr; 39(2):159-170. PubMed ID: 33781656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of hydroxychloroquine for managing glycemia in type-2 diabetes: A systematic review and meta-analysis.
    Dutta D; Jindal R; Mehta D; Kumar M; Sharma M
    J Postgrad Med; 2022; 68(2):85-92. PubMed ID: 35466661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
    Zang Y; Han X; He M; Shi J; Li Y
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):775-782. PubMed ID: 32892293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
    Wang SQ; Zhang LW; Wei P; Hua H
    BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials.
    Amani B; Khanijahani A; Amani B
    Sci Rep; 2021 Jun; 11(1):11974. PubMed ID: 34099745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    García-Albéniz X; Del Amo J; Polo R; Morales-Asencio JM; Hernán MA
    Eur J Epidemiol; 2022 Aug; 37(8):789-796. PubMed ID: 35943669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
    Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
    Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.